Loading...
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passively administered antibodies are among the most promising therapeutic and prophylactic anti-SARS-CoV-2 agents. However, the...
Na minha lista:
| Udgivet i: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cold Spring Harbor Laboratory
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386497/ https://ncbi.nlm.nih.gov/pubmed/32743579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.21.214759 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|